Member Info for Servalan

If they don't start making some bloody money you won't have to sell, the decision will be made for you!

All very positive but I hope it isn't in advance of another offering and just a genuine market reaction to an undervalued small pharma.

Cizzle getting on with it in the US, up 20% plus today. Meanwhile, Angle keeps praying for an Angel to save them.

It has a lot of potential, just look at the NHS England Rx graph, only going one way. They are doing the right things and just need to stick to the course they are on. Biotechs/small pharmas are having a bit of a moment and *when* US interest rates come down they'll have another. Yes, it's a UK company but the tail doesn't wag the dog as far as the market goes. This remains hugely undervalued in my opinion.

It needs a change of leadership. This would never be tolerated in a US energy company. Why does the UK put up with this mediocrity? Just look at the sp over the years and all the excuses. but, but, but.. the divi? I'd rather have half the divi and a fairly priced company.

Was it any different under the wasted years of conservative rule post Brown?

May Rx figures in for NHS England May 2025 : £134,389 (vs £119,552 April 2025; £97,333 May 2024). Great progress!

A last desperate share offering or delist?

I've supported Angle as much as possible but cannot any longer. Great product but even giving them benefit of the doubt - post-covid biotech crash, high interest rates, unsupportive NHS - this company, like so many other biotechs, is led by a monstrous ego who thinks he can save the world. They should never be allowed to become ceos in the first place. That disastrous proactive investor interview a while back was a prescient warning. I wish I hadn't ignored it.

Played with like a dog with a chew toy. It's like a x3 leveraged etf but only to the downside. What is the point being invested in a UK company smacked around by US banks? Back to 150 again.

Good right up in MoneyWeek today by Dominic Frisby. Sees Harbour as best bet of all the North Sea oilers. "it pays a yield that minimises your risk and compensates you for holding it. I own it, and I'm down only 25% so far. Any change in legislation and the stock could rocket."

Bots,

Another way to look at it is the US is using Israel to do its dirty work for it. Let Israel finish off the death cult and Iran's nuke ambitions. Israel couldn't care less what the world thinks of it, never has. It's a porcupine surrounded by a pack of hyenas.

...if you think I'm a child (?? weirdo!) that makes it all the more embarrassing for you.

do please share with us your vast experience running a biotech in 2025 with the whole sector dying on its ****. "overpaid", "ineffective" (caps of course, for extra shoutiness) - what do you think they should be paid? the going rate for a biotech or less because your shares are not up in value and you are angry?

where are the protestors? - how about you protest? of course you won't. somebody else do something!

get rid of the incompetents! - please demonstrate to us how you are competent to run the company. send them your c.v.

you sound like you know it all. or maybe you just sound very pompous.

Blatant lying from a desperate company seeing their SP and salaries disappearing? noooo, not possible...

An embarrassment to Ghana and Africa. The reputation these countries have is well deserved.

The entire sector is being smashed by institutional shorting, mostly by big banks (JP Morgan et al) and hedge funds. Suggesting that Angle can wave a magic wand and hey presto its 50p+ is fantasy land in this climate. BP is sitting on huge, absolutely huge amounts of cash but with tariff shenanigans and tanning dad worm brain in charge in the US leading a race to the bottom as far as health science is concerned they will not spend it yet. That will change when the climate and the risk-return improves. It's out of Angle's hand so stop with the "competency" criticism. You have no idea the challenges they are facing.

Ain't that the truth. The vast majority here have ZERO experience in the biotech/pharma world and are having a mantrum because it hasn't 10 bagged since they bought it, and bought too much. If they had any idea at all how desperate things are in the sector, financially, politically, technically they would be applauding Angle for what they have achieved so far. The games with the share price are largely out of their hands at the moment.

March numbers in on OpenPrescribing - £121,700 (vs £73,478 March 2024). Continuing to trend higher.

From 500 to under 150 in 3 years. How is this company's leadership able to dismiss this? If this was the US there would have been changes by now. She has taken millions in pay but the sp drops, week after week. It isn't just market conditions, this underperformance has been going on for ages. A change at the top is long overdue or get it sold.